ISO 27001 Certificate
SOC 1 Type I Certificate
SOC 2 Type II Certificate
PCI DSS
HIPAA
RGPD
Internal validation & live display
Multiple badges & continuous verification
Faster underwriting decisions
ISOSOC2 Type 1SOC2 Type 2PCI DSSHIPAAGDPR

Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data. We enable physicians to make real-time, data-driven decisions to deliver personalized care and targeted therapies for patients through our analytical machine learning platform that uses the power of artificial intelligence in healthcare. We also work with partners to facilitate discovery, development, and delivery of optimized therapeutic options for patients through distinctive solution sets. Our mission is for each patient to benefit from the treatment of others who came before by providing the healthcare industry tools that learn as we gather more data. It’s About Time. For more information, visit tempus.com and follow us on Twitter (@TempusLabs).

Tempus AI A.I CyberSecurity Scoring

Tempus AI

Company Details

Linkedin ID:

tempusai

Employees number:

1,001-5,000 employees

Number of followers:

102,957

NAICS:

541714

Industry Type:

Biotechnology Research

Homepage:

tempus.com

IP Addresses:

0

Company ID:

TEM_2104715

Scan Status:

In-progress

AI scoreTempus AI Risk Score (AI oriented)

Between 750 and 799

https://images.rankiteo.com/companyimages/tempusai.jpeg
Tempus AI Biotechnology Research
Updated:
  • Powered by our proprietary A.I cyber incident model
  • Insurance preferes TPRM score to calculate premium
globalscoreTempus AI Global Score (TPRM)

XXXX

https://images.rankiteo.com/companyimages/tempusai.jpeg
Tempus AI Biotechnology Research
  • Instant access to detailed risk factors
  • Benchmark vs. industry & size peers
  • Vulnerabilities
  • Findings

Tempus AI Company CyberSecurity News & History

Past Incidents
0
Attack Types
0
No data available
Ailogo

Tempus AI Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

🔒
Incident Predictions locked
Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

🔒
A.I. Risk Score Predictions locked
Access Monitoring Plan
statics

Underwriter Stats for Tempus AI

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for Tempus AI in 2025.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Tempus AI in 2025.

Incident Types Tempus AI vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Tempus AI in 2025.

Incident History — Tempus AI (X = Date, Y = Severity)

Tempus AI cyber incidents detection timeline including parent company and subsidiaries

Tempus AI Company Subsidiaries

SubsidiaryImage

Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data. We enable physicians to make real-time, data-driven decisions to deliver personalized care and targeted therapies for patients through our analytical machine learning platform that uses the power of artificial intelligence in healthcare. We also work with partners to facilitate discovery, development, and delivery of optimized therapeutic options for patients through distinctive solution sets. Our mission is for each patient to benefit from the treatment of others who came before by providing the healthcare industry tools that learn as we gather more data. It’s About Time. For more information, visit tempus.com and follow us on Twitter (@TempusLabs).

Loading...
similarCompanies

Tempus AI Similar Companies

The National Institutes of Health

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness an

Roche

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to eac

Charles River Laboratories

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all

bioMérieux

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in v

Amgen

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s

Syneos Health

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals w

Eurofins

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to eva

Agilent Technologies

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product

Thermo Fisher Scientific

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research,

newsone

Tempus AI CyberSecurity News

November 24, 2025 02:00 PM
TEM vs. BFLY: Which Stock Offers Greater Upside Amid Health Tech Boom?

Per Cornell Jeb E. Brooks School of Public Policy report, the healthcare landscape is constantly evolving, shaped by advances in technology,...

November 05, 2025 08:00 AM
Tempus AI (TEM): Losses Deepen, Profitability Still Elusive Despite 62.68% Earnings Growth Forecast

Tempus AI (TEM) remains unprofitable, with its net profit margin showing no improvement over the past year and annual losses having...

November 04, 2025 08:00 AM
Tempus AI dives after-hours despite strong Q3 numbers

The medical diagnostic company, which is developing new AI-driven tests, has at times been a favorite of retail investors....

November 04, 2025 08:00 AM
Tempus AI (TEM): Reassessing Valuation After Strong Results and Raised Guidance

Tempus AI (TEM) has caught the attention of investors this week after reporting stronger than expected quarterly sales and margins.

September 27, 2025 07:00 AM
What Are 2 Great Tech Stocks to Buy Right Now?

There's no doubt about it. The technology sector has been a great place to invest for decades. Indeed, since 2010, the tech-heavy Nasdaq...

September 22, 2025 07:00 AM
Salt AI Raises $10M to Advance Contextual AI in Life Sciences

Salt AI secured $10M in funding led by Morpheus Ventures to expand its contextual AI platform for life sciences and health tech.

September 21, 2025 07:00 AM
Tempus AI Surges Since IPO as FDA Clearance Boosts Growth Outlook

Tempus AI, Inc. (NASDAQ:TEM) is one of the 11 Best Performing IPOs in the Last 2 Years. The stock's price target is raised following a...

September 16, 2025 07:00 AM
Tempus AI

Tempus is a technology company leading the adoption of AI to advance precision medicine and patient care.

September 12, 2025 07:00 AM
Tempus AI: TEM Stock To $400?

The opportunity for Tempus AI may not stop at a 2x return. It could potentially be a 10x story or more.

faq

Frequently Asked Questions

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.

Tempus AI CyberSecurity History Information

Official Website of Tempus AI

The official website of Tempus AI is http://www.tempus.com.

Tempus AI’s AI-Generated Cybersecurity Score

According to Rankiteo, Tempus AI’s AI-generated cybersecurity score is 785, reflecting their Fair security posture.

How many security badges does Tempus AI’ have ?

According to Rankiteo, Tempus AI currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Does Tempus AI have SOC 2 Type 1 certification ?

According to Rankiteo, Tempus AI is not certified under SOC 2 Type 1.

Does Tempus AI have SOC 2 Type 2 certification ?

According to Rankiteo, Tempus AI does not hold a SOC 2 Type 2 certification.

Does Tempus AI comply with GDPR ?

According to Rankiteo, Tempus AI is not listed as GDPR compliant.

Does Tempus AI have PCI DSS certification ?

According to Rankiteo, Tempus AI does not currently maintain PCI DSS compliance.

Does Tempus AI comply with HIPAA ?

According to Rankiteo, Tempus AI is not compliant with HIPAA regulations.

Does Tempus AI have ISO 27001 certification ?

According to Rankiteo,Tempus AI is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Industry Classification of Tempus AI

Tempus AI operates primarily in the Biotechnology Research industry.

Number of Employees at Tempus AI

Tempus AI employs approximately 1,001-5,000 employees people worldwide.

Subsidiaries Owned by Tempus AI

Tempus AI presently has no subsidiaries across any sectors.

Tempus AI’s LinkedIn Followers

Tempus AI’s official LinkedIn profile has approximately 102,957 followers.

NAICS Classification of Tempus AI

Tempus AI is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Tempus AI’s Presence on Crunchbase

No, Tempus AI does not have a profile on Crunchbase.

Tempus AI’s Presence on LinkedIn

Yes, Tempus AI maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/tempusai.

Cybersecurity Incidents Involving Tempus AI

As of November 27, 2025, Rankiteo reports that Tempus AI has not experienced any cybersecurity incidents.

Number of Peer and Competitor Companies

Tempus AI has an estimated 4,337 peer or competitor companies worldwide.

Tempus AI CyberSecurity History Information

How many cyber incidents has Tempus AI faced ?

Total Incidents: According to Rankiteo, Tempus AI has faced 0 incidents in the past.

What types of cybersecurity incidents have occurred at Tempus AI ?

Incident Types: The types of cybersecurity incidents that have occurred include .

Incident Details

What are the most common types of attacks the company has faced ?

Additional Questions

cve

Latest Global CVEs (Not Company-Specific)

Description

Angular is a development platform for building mobile and desktop web applications using TypeScript/JavaScript and other languages. Prior to versions 19.2.16, 20.3.14, and 21.0.1, there is a XSRF token leakage via protocol-relative URLs in angular HTTP clients. The vulnerability is a Credential Leak by App Logic that leads to the unauthorized disclosure of the Cross-Site Request Forgery (XSRF) token to an attacker-controlled domain. Angular's HttpClient has a built-in XSRF protection mechanism that works by checking if a request URL starts with a protocol (http:// or https://) to determine if it is cross-origin. If the URL starts with protocol-relative URL (//), it is incorrectly treated as a same-origin request, and the XSRF token is automatically added to the X-XSRF-TOKEN header. This issue has been patched in versions 19.2.16, 20.3.14, and 21.0.1. A workaround for this issue involves avoiding using protocol-relative URLs (URLs starting with //) in HttpClient requests. All backend communication URLs should be hardcoded as relative paths (starting with a single /) or fully qualified, trusted absolute URLs.

Risk Information
cvss4
Base: 7.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Forge (also called `node-forge`) is a native implementation of Transport Layer Security in JavaScript. An Uncontrolled Recursion vulnerability in node-forge versions 1.3.1 and below enables remote, unauthenticated attackers to craft deep ASN.1 structures that trigger unbounded recursive parsing. This leads to a Denial-of-Service (DoS) via stack exhaustion when parsing untrusted DER inputs. This issue has been patched in version 1.3.2.

Risk Information
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Forge (also called `node-forge`) is a native implementation of Transport Layer Security in JavaScript. An Integer Overflow vulnerability in node-forge versions 1.3.1 and below enables remote, unauthenticated attackers to craft ASN.1 structures containing OIDs with oversized arcs. These arcs may be decoded as smaller, trusted OIDs due to 32-bit bitwise truncation, enabling the bypass of downstream OID-based security decisions. This issue has been patched in version 1.3.2.

Risk Information
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Suricata is a network IDS, IPS and NSM engine developed by the OISF (Open Information Security Foundation) and the Suricata community. Prior to versions 7.0.13 and 8.0.2, working with large buffers in Lua scripts can lead to a stack overflow. Users of Lua rules and output scripts may be affected when working with large buffers. This includes a rule passing a large buffer to a Lua script. This issue has been patched in versions 7.0.13 and 8.0.2. A workaround for this issue involves disabling Lua rules and output scripts, or making sure limits, such as stream.depth.reassembly and HTTP response body limits (response-body-limit), are set to less than half the stack size.

Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Description

Suricata is a network IDS, IPS and NSM engine developed by the OISF (Open Information Security Foundation) and the Suricata community. In versions from 8.0.0 to before 8.0.2, a NULL dereference can occur when the entropy keyword is used in conjunction with base64_data. This issue has been patched in version 8.0.2. A workaround involves disabling rules that use entropy in conjunction with base64_data.

Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

Access Data Using Our API

SubsidiaryImage

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=tempusai' -H 'apikey: YOUR_API_KEY_HERE'

What Do We Measure ?

revertimgrevertimgrevertimgrevertimg
Incident
revertimgrevertimgrevertimgrevertimg
Finding
revertimgrevertimgrevertimgrevertimg
Grade
revertimgrevertimgrevertimgrevertimg
Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network Security

Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)

Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)

Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat Intelligence

Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Top LeftTop RightBottom LeftBottom Right
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
Users Love Us Badge